Alpha 2.0
Login Register
» Articles » PMID: 17508004

A Novel ETV6-PDGFRB Fusion Transcript Missed by Standard Screening in a Patient with an Imatinib Responsive Chronic Myeloproliferative Disease

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2007 May 18
PMID 17508004
Citations 8
Authors
C E Curtis
F H Grand
K Waghorn
T P Sahoo
J George
N C P Cross
Affiliations
Soon will be listed here.
Citing Articles

Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.

Nguyen L, Saha A, Kuykendall A, Zhang L Cancers (Basel). 2024; 16(7).

PMID: 38611061 PMC: 11011008. DOI: 10.3390/cancers16071383.

Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.

van Outersterp I, Tasian S, Reichert C, Boeree A, de Groot-Kruseman H, Escherich G Blood. 2024; 143(21):2178-2189.

PMID: 38394665 PMC: 11143520. DOI: 10.1182/blood.2023023120.

Myeloproliferative Neoplasm Driven by in an Adolescent with Recent History of Burkitt Leukemia.

Renzi S, Algawahmed F, Davidson S, Langenberg K, Fuligni F, Ali S Curr Oncol. 2023; 30(7):5946-5952.

PMID: 37503586 PMC: 10378670. DOI: 10.3390/curroncol30070444.

Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.

Stella S, Massimino M, Manzella L, Pennisi M, Tirro E, Romano C Int J Mol Sci. 2021; 22(2).

PMID: 33418988 PMC: 7825323. DOI: 10.3390/ijms22020486.

Multiple - fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11).

Sheng G, Zeng Z, Pan J, Kou L, Wang Q, Yao H Mol Cytogenet. 2017; 10:4.

PMID: 28261327 PMC: 5329908. DOI: 10.1186/s13039-017-0306-8.